Claims
- 1. A method of treating animals which method comprises administering to the animal an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a veterinarily active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20.degree. C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20.degree. C. to rupture the envelope.
- 2. A method according to claim 1 wherein the animal is a ruminant.
- 3. A method of treating a human patient which method comprises administering to the patient an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a pharmaceutically active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20.degree. C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20.degree. C. to rupture the envelope.
- 4. A device for sustained release of an active ingredient in the stomach of a human or animal, which device comprises an envelope having flexible water-permeable and porous walls of perforated plastic, knitted, braid or woven material, the envelope containing particulate water-insoluble hydrogel in a pharmaceutically, veterinarily or biologically active ingredient in sustained release form in the closed envelope wherein the volume of the hydrogel when fully swollen in water at 20.degree. C. amounts to at least 66% of the maximum non-stretched internal volume of the envelope and is sufficient to retain the device within the stomach of the human or animal during the sustained release of the active ingredient but is insufficient when fully swollen in water at 20.degree. C. to rupture the envelope.
- 5. The envelope according to claim 4, wherein the quantity of hydrogel when fully swollen in water at 20.degree. C. amounts to at least 100% of the given maximum non-stretched internal volume.
- 6. The envelope according to claim 4, wherein the hydrogel is a crosslinked polyethylene glycol.
- 7. The envelope according to claim 4, which contains a mixture of hydrogel particles and particles of active ingredient in sustained release form.
- 8. The envelope according to claim 4, wherein the active ingredient in sustained release form is contained in the hydrogel particles.
- 9. The envelope according to claim 4, wherein the quantity of hydrogel when fully swollen in water at 20.degree. C. ranges from 90 to 110% of the given maximum non-stretched internal volume of the envelope.
- 10. The envelope according to claim 4, wherein the average particle size of the hydrogel particles is at least 1% larger than the pores of the surrounding envelope.
- 11. The envelope according to claim 10, wherein said average particle size is at least twice the size of the pores of the surrounding envelope.
- 12. The envelope according to claim 4, wherein the hydrogel is one that upon swelling absorbs more than 40% of its dry weight of water without dissolution.
- 13. The envelope according to claim 12, wherein the degree of swelling of the hydrogel ranges between 150 and 1000% by weight.
- 14. The envelope according to claim 4, which is in the form of a toroid.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8305797 |
Mar 1983 |
GBX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/229,725, filed on Aug. 5, 1988, now abandoned, which is a continuation of Ser. No. 06/818,076 filed Jan. 13, 1986 now abandoned, which is a continuation of Ser. No. 06/585,541 filed Mar. 2, 1984 now abandoned.
US Referenced Citations (12)
Foreign Referenced Citations (5)
Number |
Date |
Country |
513656 |
|
AUX |
1118430 |
Jul 1968 |
GBX |
1204900 |
Sep 1970 |
GBX |
1437835 |
Jun 1976 |
GBX |
2086400 |
May 1982 |
GBX |
Non-Patent Literature Citations (2)
Entry |
Chem. Abs., 95, No. 10, 49345A. |
Chem. Abs., 95, No. 4, 47886y. |
Continuations (3)
|
Number |
Date |
Country |
Parent |
229725 |
Aug 1988 |
|
Parent |
818076 |
Jan 1986 |
|
Parent |
585541 |
Mar 1984 |
|